Li C. Liu

169 Donghu Road
Wuhan, 430071, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 459 publications

SAM-BoMu: Boundary-Aware Multi-Channel Fusion Network for Precise Polyp Segmentation.

SAM-BoMu: Boundary-Aware Multi-Channel Fusion Network for Precise Polyp Segmentation.

Journal: IEEE journal of biomedical and health informatics
Published: July 27, 2026

The Association of Social and Biological Factors with Clinical Outcomes in Patients with Lung Cancer and DNA Damage Repair Pathway Mutations: A Single-Institution Experience.

The Association of Social and Biological Factors with Clinical Outcomes in Patients with Lung Cancer and DNA Damage Repair Pathway Mutations: A Single-Institution Experience.

Journal: Cancers
Published: June 27, 2026

Reparative Outcomes in Corneal Infection: Linking Adjunctive Tβ4 Treatment to Nerve Regeneration and Visual Function.

Reparative Outcomes in Corneal Infection: Linking Adjunctive Tβ4 Treatment to Nerve Regeneration and Visual Function.

Journal: Investigative ophthalmology & visual science
Published: June 12, 2026

Germline regulation of tumor evolutionary dynamics shapes multiple myeloma progression.

Germline regulation of tumor evolutionary dynamics shapes multiple myeloma progression.

Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026

Convergent Evolution in Tumor Genomes Targets Functional Domains.

Convergent Evolution in Tumor Genomes Targets Functional Domains.

Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026

SELENOF functions as a tumor suppressor in skin cancer.

SELENOF functions as a tumor suppressor in skin cancer.

Journal: Redox biology
Published: June 11, 2026

Payload-Free [89Zr]Zr-DFO*-sq-Enfortumab ImmunoPET for Imaging Nectin-4 Expression in Bladder Cancer.

Payload-Free [89Zr]Zr-DFO*-sq-Enfortumab ImmunoPET for Imaging Nectin-4 Expression in Bladder Cancer.

Journal: Molecular pharmaceutics
Published: May 27, 2026

Long-term safety, tolerability, and efficacy of subcutaneous efgartigimod PH20 in generalized myasthenia gravis: final results from a phase 3 open-label extension study (ADAPT-SC+).

Long-term safety, tolerability, and efficacy of subcutaneous efgartigimod PH20 in generalized myasthenia gravis: final results from a phase 3 open-label extension study (ADAPT-SC+).

Journal: Frontiers in neurology
Published: May 08, 2026

Training Perspectives from the NIH T32 Artificial Intelligence for Precision Nutrition Programs.

Training Perspectives from the NIH T32 Artificial Intelligence for Precision Nutrition Programs.

Journal: The Journal of nutrition
Published: May 04, 2026

Feeding Mode Is Associated with Infant Night Sleep Trajectories During the First Postnatal Year.

Feeding Mode Is Associated with Infant Night Sleep Trajectories During the First Postnatal Year.

Journal: Nutrients
Published: April 22, 2026

Investigating Age-Dependent Oxygenation and Blood Perfusion in a Mouse Model of Peripheral Artery Disease (PAD) Using Multispectral Optoacoustic Tomography (MSOT), Laser Speckle Contrast Imaging (LSCI) and Histology.

Investigating Age-Dependent Oxygenation and Blood Perfusion in a Mouse Model of Peripheral Artery Disease (PAD) Using Multispectral Optoacoustic Tomography (MSOT), Laser Speckle Contrast Imaging (LSCI) and Histology.

Journal: Diagnostics (Basel, Switzerland)
Published: March 27, 2026

Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical Validation Working Group Consensus Recommendation.

Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical Validation Working Group Consensus Recommendation.

Journal: JCO precision oncology
Published: January 14, 2026
Showing 1-12 of 459

Last Updated: 09/26/2026